(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide

C254H297N45O16 — CID 158115257

IUPAC(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide
SMILESCCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)cn2)c2ccccc2)cc1
InChIInChI=1S/6C29H35N5O2.C28H33N5O2.2C26H27N5O/c6*1-4-33-16-17-34(20-27(33)35)25-14-15-26(30-19-25)32-29(36)28(24-8-6-5-7-9-24)31-18-22(3)23-12-10-21(2)11-13-23;1-20-9-11-22(12-10-20)21(2)17-30-27(23-7-5-4-6-8-23)28(35)31-25-14-13-24(18-29-25)33-16-15-32(3)26(34)19-33;2*1-18-8-10-20(11-9-18)19(2)14-28-25(21-6-4-3-5-7-21)26(32)31-24-13-12-22(15-27-24)23-16-29-30-17-23/h6*5-15,19,22,28,31H,4,16-18,20H2,1-3H3,(H,30,32,36);4-14,18,21,27,30H,15-17,19H2,1-3H3,(H,29,31,35);2*3-13,15-17,19,25,28H,14H2,1-2H3,(H,29,30)(H,27,31,32)/t3*22-,28+;3*22-,28-;21-,27+;2*19-,25-/m110110110/s1
InChIKeyFQXQAJMTCGJRCJ-YLEGHXTMSA-N
MW4236.47 g/mol
LogP38.24
Rot. Bonds78

About (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide

(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide (PubChem CID 158115257) has the molecular formula C254H297N45O16 and a molecular weight of 4236.47 g/mol. Its IUPAC name is (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide.

Molecular Properties

Compound Name(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide
PubChem CID158115257
Molecular FormulaC254H297N45O16
Molecular Weight4236.47 g/mol
Exact Mass4233.38
IUPAC Name(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide
SMILESCCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)cn2)c2ccccc2)cc1
InChIInChI=1S/6C29H35N5O2.C28H33N5O2.2C26H27N5O/c6*1-4-33-16-17-34(20-27(33)35)25-14-15-26(30-19-25)32-29(36)28(24-8-6-5-7-9-24)31-18-22(3)23-12-10-21(2)11-13-23;1-20-9-11-22(12-10-20)21(2)17-30-27(23-7-5-4-6-8-23)28(35)31-25-14-13-24(18-29-25)33-16-15-32(3)26(34)19-33;2*1-18-8-10-20(11-9-18)19(2)14-28-25(21-6-4-3-5-7-21)26(32)31-24-13-12-22(15-27-24)23-16-29-30-17-23/h6*5-15,19,22,28,31H,4,16-18,20H2,1-3H3,(H,30,32,36);4-14,18,21,27,30H,15-17,19H2,1-3H3,(H,29,31,35);2*3-13,15-17,19,25,28H,14H2,1-2H3,(H,29,30)(H,27,31,32)/t3*22-,28+;3*22-,28-;21-,27+;2*19-,25-/m110110110/s1
InChIKeyFQXQAJMTCGJRCJ-YLEGHXTMSA-N
XLogP38.24
TPSA708.39 Ų
H-Bond Donors20
H-Bond Acceptors43
Rotatable Bonds78
Heavy Atoms315
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004236.47
LogP ≤ 538.24
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1043

Analyze (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide?
The IUPAC name of (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide (CID 158115257) is (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide.
What is the SMILES notation for (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide?
The canonical SMILES for (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide is CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.CCN1CCN(c2ccc(NC(=O)[C@H](NC[C@H](C)c3ccc(C)cc3)c3ccccc3)nc2)CC1=O.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(N3CCN(C)C(=O)C3)cn2)c2ccccc2)cc1.
What is the InChIKey of (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide?
The InChIKey is FQXQAJMTCGJRCJ-YLEGHXTMSA-N. The full InChI is InChI=1S/6C29H35N5O2.C28H33N5O2.2C26H27N5O/c6*1-4-33-16-17-34(20-27(33)35)25-14-15-26(30-19-25)32-29(36)28(24-8-6-5-7-9-24)31-18-22(3)23-12-10-21(2)11-13-23;1-20-9-11-22(12-10-20)21(2)17-30-27(23-7-5-4-6-8-23)28(35)31-25-14-13-24(18-29-25)33-16-15-32(3)26(34)19-33;2*1-18-8-10-20(11-9-18)19(2)14-28-25(21-6-4-3-5-7-21)26(32)31-24-13-12-22(15-27-24)23-16-29-30-17-23/h6*5-15,19,22,28,31H,4,16-18,20H2,1-3H3,(H,30,32,36);4-14,18,21,27,30H,15-17,19H2,1-3H3,(H,29,31,35);2*3-13,15-17,19,25,28H,14H2,1-2H3,(H,29,30)(H,27,31,32)/t3*22-,28+;3*22-,28-;21-,27+;2*19-,25-/m110110110/s1.
What are the key properties of (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide?
(2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide has a molecular weight of 4236.47 g/mol, XLogP of 38.24, 78 rotatable bonds, 20 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2R)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;bis((2S)-N-[5-(4-ethyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide);(2S)-N-[5-(4-methyl-3-oxopiperazin-1-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenyl-N-[5-(1H-pyrazol-4-yl)-2-pyridinyl]acetamide is sourced from PubChem (CID 158115257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).